0.00Open0.15Pre Close0 Volume607 Open Interest17.50Strike Price0.00Turnover7460.65%IV246.76%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier-3DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type0.1067Delta0.0474Gamma33.93Leverage Ratio-9.1645Theta0.0000Rho3.62Eff Leverage0.0001Vega
Applied Therapeutics Stock Discussion
$Applied Therapeutics(APLT.US)$
The biopharmaceutical company said Thursday that the Food and Drug Administration now has a target action date of Nov. 28 for its application, compared with the previous date of Aug. 28.
The company's application is for govorestat in the treatment of Galactosemia, a rare genetic condition that makes patients unable to metab...
In a significant development for the healthcare sector and investors worldwide, Applied Therapeutics Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company, has announced the Food and Drug Administration's acceptance and priority review of t...
No comment yet